Smith & Nephew plc Share Price Today: Live Updates & Key Insights
Smith & Nephew plc share price today is $33.04, up -0.96%. The stock opened at $33.34 against the previous close of $33.36, with an intraday high of $33.65 and low of $33.01.
Smith & Nephew plc Share Price Chart
Smith & Nephew plc
Smith & Nephew plc Share Price Performance
Smith & Nephew plc Institutional Holdings
Smith & Nephew plc Market Status
Smith & Nephew plc Fundamentals
Market Cap 14161.14 M
PB Ratio 2.6775
PE Ratio 23.3287
Enterprise Value 16935.73 M
Total Assets 10457.00 M
Volume 692405
Smith & Nephew plc Company Financials
About Smith & Nephew plc & investment objective
Company Information Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom, the United States, and internationally. It operates in three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products. It also provides sports medicine joint repair products comprise instruments, technologies, and implants to perform minimally invasive surgery, as well as treating soft tissue injuries and degenerative conditions of the shoulder, knee, hip, and small joints. In addition, the company offers arthroscopic enabling technologies comprising fluid management equipment for surgical access, cameras, digital image capture, scopes, light sources, and monitors to assist with visualization inside the joints, radio frequency, electromechanical and mechanical tissue resection devices, and hand instruments for removing damaged tissue; and ear, nose, and throat solutions. Further, it provides advanced wound care products for the treatment and prevention of acute and chronic wounds, leg, diabetic and pressure ulcers, burns, and post-operative wounds; advanced wound bioactives, such as biologics and other bioactive technologies for debridement and dermal repair/regeneration, and regenerative medicine products, including skin, bone graft, and articular cartilage substitutes; and advanced wound devices, such as traditional and single-use negative pressure wound therapy, and hydrosurgery systems. The company serves the healthcare providers. Smith & Nephew plc was founded in 1856 and is headquartered in Watford, the United Kingdom.
Organisation Medical Devices
Employees 17000
Industry Medical Devices
CEO Dr. Deepak S. Nath Ph.D.
Trading and brokerage services provided by
Technology Services provided by Motilal Oswal Financial Services:
Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*
Take your next step
